World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
50
Citations
10382
World Ranking
4227
National Ranking
1927

John D. Roback publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where John D. Roback sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 281 publications — 59th percentile

59% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

John D. Roback D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where John D. Roback sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 50 D-Index — 15th percentile

15% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

John D. Roback is an academic affiliated with Emory University in the United States. Their research primarily focuses on medicine, with a significant emphasis on infectious diseases, hematology, physiology, genetics, and molecular biology.

The scientist's work covers several key topics, including:

  • SARS-CoV-2 and COVID-19 research
  • Blood groups and transfusion
  • COVID-19 clinical research studies
  • SARS-CoV-2 detection and testing
  • Erythrocyte function and pathophysiology
  • Blood transfusion and management
  • Hemoglobinopathies and related disorders

Notable recent papers by John D. Roback include:

  • Rapid Generation of Neutralizing Antibody Responses in COVID-19 Patients, 2020, Cell Reports Medicine
  • Convalescent Plasma to Treat COVID-19, 2020, JAMA
  • Rapid Generation of Neutralizing Antibody Responses in COVID-19 Patients, 2020, bioRxiv (Cold Spring Harbor Laboratory)
  • The SARS-CoV-2 Receptor-Binding Domain Preferentially Recognizes Blood Group A, 2021, Blood Advances
  • Quantification of Occupational and Community Risk Factors for SARS-CoV-2 Seropositivity Among Health Care Workers in a Large U.S. Health Care System, 2021, Annals of Internal Medicine

Frequent co-authors collaborating with Roback include:

  • Sean R. Stowell
  • Andrew S. Neish
  • Hans Verkerke
  • Narayanaiah Cheedarla
  • Cassandra D. Josephson

The main publication venues where Roback's work appears are:

  • Transfusion
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Blood
  • Open Forum Infectious Diseases
  • Blood Advances

John D. Roback's research contributions are concentrated largely on infectious diseases and hematology, with a substantial body of work addressing COVID-19 and blood transfusion topics. Their presence in both peer-reviewed journals and preprint repositories illustrates participation in rapid dissemination of findings, particularly in the context of the SARS-CoV-2 pandemic.

Best Publications

  • Convalescent Plasma to Treat COVID-19: Possibilities and Challenges.

    John D. Roback;Jeannette Guarner

  • Recipient inflammation affects the frequency and magnitude of immunization to transfused red blood cells

    Jeanne E. Hendrickson;Maxime Desmarets;Seema S. Deshpande;Traci E. Chadwick

  • Blood Transfusion and Breast Milk Transmission of Cytomegalovirus in Very Low-Birth-Weight Infants A Prospective Cohort Study

    Cassandra D. Josephson;Angela M. Caliendo;Kirk A. Easley;Andrea Knezevic

  • Inflammation enhances consumption and presentation of transfused RBC antigens by dendritic cells.

    Jeanne E. Hendrickson;Traci E. Chadwick;John D. Roback;Christopher D. Hillyer

  • Platelets confound the measurement of extracellular miRNA in archived plasma.

    Adam J. Mitchell;Warren D. Gray;Salim S. Hayek;Yi-An Ko

  • CMV DNA is rarely detected in healthy blood donors using validated PCR assays.

    John D. Roback;W. Lawrence Drew;Megan E. Laycock;Deborah Todd

  • The effect of platelet lysate fibrinogen on the functionality of MSCs in immunotherapy.

    Ian B. Copland;Marco A. Garcia;Edmund K. Waller;John D. Roback

  • Daratumumab (anti-CD38) induces loss of CD38 on red blood cells

    Harold C. Sullivan;Christian Gerner-Smidt;Ajay K. Nooka;Connie M. Arthur

  • The SARS-CoV-2 receptor-binding domain preferentially recognizes blood group A.

    Shang-Chuen Wu;Connie M Arthur;Jianmei Wang;Hans Verkerke

  • Metabolic pathways that correlate with post-transfusion circulation of stored murine red blood cells.

    Karen de Wolski;Xiaoyoun Fu;Larry J. Dumont;John D. Roback

  • IFN-γ and indoleamine 2,3-dioxygenase signaling between donor dendritic cells and T cells regulates graft versus host and graft versus leukemia activity.

    Ying Lu;Cynthia R. Giver;Akshay Sharma;Jian Ming Li

  • BDNF‐activated Sianal Transduction in Rat Cortical Glial Cells

    John D. Roback;H. Nicholas Marsh;Martha Downen;H. Clive Palfrey

  • Latent cytomegalovirus infection exacerbates experimental colitis.

    Chukwuma Onyeagocha;Mohammad S. Hossain;Amrita Kumar;Rheinallt M. Jones

  • Determinants of Neutralizing Antibody Response After SARS CoV-2 Vaccination in Patients With Myeloma

    Unknown

  • Multidisciplinary assessment of the Abbott BinaxNOW SARS-CoV-2 point-of-care antigen test in the context of emerging viral variants and self-administration.

    Jennifer K. Frediani;Joshua M. Levy;Anuradha Rao;Leda Bassit

  • Discrete Toll-like receptor agonists have differential effects on alloimmunization to transfused red blood cells

    Jeanne E. Hendrickson;John D. Roback;Christopher D. Hillyer;Kirk A. Easley

  • Flagellin, a TLR5 Agonist, Reduces Graft-versus-Host Disease in Allogeneic Hematopoietic Stem Cell Transplantation Recipients While Enhancing Antiviral Immunity

    Mohammad S. Hossain;David L. Jaye;Brian P. Pollack;Brian P. Pollack;Alton B. Farris

  • An automatable format for accurate immunohematology testing by flow cytometry.

    John D. Roback;Sheilagh Barclay;Christopher D. Hillyer

  • Anemia induces gut inflammation and injury in an animal model of preterm infants

    Connie M. Arthur;Demet Nalbant;Henry A. Feldman;Bejan J. Saeedi

  • Marginal zone B cells mediate a CD4 T-cell-dependent extrafollicular antibody response following RBC transfusion in mice.

    Patricia E Zerra;Seema R Patel;Ryan Philip Jajosky;Connie M Arthur

  • Longitudinal monitoring of WBC subsets in packed RBC units after filtration: implications for transfusion transmission of infections.

    J.D. Roback;R.A. Bray;C.D. Hillyer

  • Multiploid CD61+ cells are the pre-dominant cell lineage infected during acute dengue virus infection in bone marrow.

    Kristina B. Clark;Sansanee Noisakran;Sansanee Noisakran;Nattawat Onlamoon;Nattawat Onlamoon;Hui-Mien Hsiao

  • AABB Committee Report: reducing transfusion-transmitted cytomegalovirus infections

    Nancy M. Heddle;Nancy M. Heddle;Michael Boeckh;Brenda Grossman;Jessica Jacobson

  • The Leukocyte Antibody Prevalence Study-II (LAPS-II): a retrospective cohort study of transfusion-related acute lung injury in recipients of high-plasma-volume human leukocyte antigen antibody–positive or –negative components

    Steven H. Kleinman;Darrell J. Triulzi;Edward L. Murphy;Patricia M. Carey

  • Antibody Profiles According to Mild or Severe SARS-CoV-2 Infection, Atlanta, Georgia, USA, 2020.

    William T. Hu;J. Christina Howell;Tugba Ozturk;Karima Benameur

Frequent Co-Authors

James C. Zimring
James C. Zimring University of Washington
Kirk A. Easley
Kirk A. Easley Emory University
Edmund K. Waller
Edmund K. Waller Emory University
Steven L. Spitalnik
Steven L. Spitalnik Columbia University
Jeanne E. Hendrickson
Jeanne E. Hendrickson Yale University
Andrew T. Gewirtz
Andrew T. Gewirtz Georgia State University
Christopher R. Flowers
Christopher R. Flowers The University of Texas MD Anderson Cancer Center
Sagar Lonial
Sagar Lonial Emory University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in advancing their careers in immunology and related healthcare fields, exploring online degree options can be a strategic move. Many professionals pursue specialized programs such as the cheapest psych np programs online to enhance their qualifications without incurring excessive costs.

Understanding potential earnings is crucial when considering further education. For example, individuals earning a Doctor of Nursing Practice (DNP) often evaluate how much does a dnp make varies by state and specialization, offering insight into long-term financial benefits.

Career transitions are also common within healthcare, and those with a Family Nurse Practitioner (FNP) background might seek guidance on fnp to acute care np pathways, allowing them to move into specialized, fast-paced environments.

For accelerated advancement, professionals can consider accelerated np programs that offer a faster track to becoming a nurse practitioner. These programs are ideal for those ready to quickly expand their expertise and leadership roles.

Best Scientists Citing John D. Roback

Trending Scientists

Recently Published Articles